###begin article-title 0
###xml 67 72 <span type="species:ncbi:10090">Mouse</span>
Mast Cells and Gastrointestinal Dysmotility in the Cystic Fibrosis Mouse
###end article-title 0
###begin p 1
Conceived and designed the experiments: RCDL. Performed the experiments: RCDL LM MF RS. Analyzed the data: RCDL LM ER. Wrote the paper: RCDL.
###end p 1
###begin title 2
Background
###end title 2
###begin p 3
###xml 421 427 421 427 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">tm1UNC</sup>
###xml 417 427 417 427 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Cftr<sup>tm1UNC</sup></italic>
###xml 429 433 429 433 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Cftr</italic>
###xml 134 139 <span type="species:ncbi:10090">mouse</span>
###xml 410 415 <span type="species:ncbi:10090">mouse</span>
Cystic fibrosis (CF) has many effects on the gastrointestinal tract and a common problem in this disease is poor nutrition. In the CF mouse there is an innate immune response with a large influx of mast cells into the muscularis externa of the small intestine and gastrointestinal dysmotility. The aim of this study was to evaluate the potential role of mast cells in gastrointestinal dysmotility using the CF mouse (Cftrtm1UNC, Cftr knockout).
###end p 3
###begin title 4
Methodology
###end title 4
###begin p 5
###xml 22 26 <span type="species:ncbi:10090">mice</span>
Wild type (WT) and CF mice were treated for 3 weeks with mast cell stabilizing drugs (ketotifen, cromolyn, doxantrazole) or were treated acutely with a mast cell activator (compound 48/80). Gastrointestinal transit was measured using gavage of a fluorescent tracer.
###end p 5
###begin title 6
Results
###end title 6
###begin p 7
###xml 6 10 <span type="species:ncbi:10090">mice</span>
###xml 186 190 <span type="species:ncbi:10090">mice</span>
###xml 299 303 <span type="species:ncbi:10090">mice</span>
###xml 372 376 <span type="species:ncbi:10090">mice</span>
###xml 391 395 <span type="species:ncbi:10090">mice</span>
###xml 451 455 <span type="species:ncbi:10090">mice</span>
###xml 577 581 <span type="species:ncbi:10090">mice</span>
###xml 612 616 <span type="species:ncbi:10090">mice</span>
###xml 718 722 <span type="species:ncbi:10090">mice</span>
###xml 734 738 <span type="species:ncbi:10090">mice</span>
In CF mice gastric emptying at 20 min post-gavage did not differ from WT, but was significantly less than in WT at 90 min post-gavage. Gastric emptying was significantly increased in WT mice by doxantrazole, but none of the mast cell stabilizers had any significant effect on gastric emptying in CF mice. Mast cell activation significantly enhanced gastric emptying in WT mice but not in CF mice. Small intestinal transit was significantly less in CF mice as compared to WT. Of the mast cell stabilizers, only doxantrazole significantly affected small intestinal transit in WT mice and none had any effect in CF mice. Mast cell activation resulted in a small but significant increase in small intestinal transit in CF mice but not WT mice.
###end p 7
###begin title 8
Conclusions
###end title 8
###begin p 9
The results indicate that mast cells are not involved in gastrointestinal dysmotility but their activation can stimulate small intestinal transit in cystic fibrosis.
###end p 9
###begin title 10
Introduction
###end title 10
###begin p 11
###xml 90 94 90 94 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">CFTR</italic>
###xml 599 602 599 602 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0004283-DeLisle1">[1]</xref>
Cystic fibrosis (CF) is an autosomal recessive genetic disease caused by mutations in the CFTR (cystic fibrosis transmembrane conductance regulator) gene. CFTR is a cAMP-regulated chloride channel that in the intestine is mainly expressed in the apical plasma membrane of crypt cells. In the absence of CFTR, fluid secretion into the intestinal lumen is of low volume and is deficient in bicarbonate, which impairs neutralization of gastric acid. The poorly-hydrated acidic luminal environment is believed to cause accumulation of mucus, which fosters bacterial overgrowth of the CF small intestine [1].
###end p 11
###begin p 12
###xml 215 218 215 218 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0004283-Serna1">[2]</xref>
###xml 220 223 220 223 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0004283-Schwarz1">[3]</xref>
###xml 282 285 282 285 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0004283-Raia1">[4]</xref>
###xml 286 289 286 289 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0004283-Bruzzese1">[6]</xref>
###xml 539 542 539 542 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0004283-Fridge1">[7]</xref>
###xml 544 547 544 547 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0004283-Lewindon1">[8]</xref>
###xml 667 670 667 670 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0004283-Lewindon1">[8]</xref>
###xml 671 675 671 675 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0004283-Gregory1">[14]</xref>
###xml 245 250 <span type="species:ncbi:9606">human</span>
###xml 530 538 <span type="species:ncbi:9606">patients</span>
###xml 658 666 <span type="species:ncbi:9606">patients</span>
Hallmarks of CF in affected epithelial organs, including the intestine, are accumulation of excessive mucus, microbial infection, and inflammation. Inflammation is known to affect gastrointestinal motility patterns [2], [3]. Inflammation of the human CF intestine has been reported [4]-[6] but, because such studies use indirect measures or require invasive methods, there is not much detailed information. Inflammation of the CF intestine may be a response to bacterial overgrowth, which is reported to occur in up to half of CF patients [7], [8]. Consistent with intestinal inflammation, gastrointestinal dysmotility has been reported to be frequent in CF patients [8]-[14].
###end p 12
###begin p 13
###xml 4 8 4 8 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Cftr</italic>
###xml 29 35 29 35 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">tm1UNC</sup>
###xml 25 35 25 35 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Cftr<sup>tm1UNC</sup></italic>
###xml 244 248 244 248 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0004283-DeLisle2">[15]</xref>
###xml 250 254 250 254 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0004283-Norkina1">[16]</xref>
###xml 418 422 418 422 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0004283-Norkina2">[17]</xref>
###xml 18 23 <span type="species:ncbi:10090">mouse</span>
###xml 40 45 <span type="species:ncbi:10090">mouse</span>
###xml 114 122 <span type="species:ncbi:9606">patients</span>
###xml 279 284 <span type="species:ncbi:10090">mouse</span>
The Cftr knockout mouse (Cftrtm1UNC, CF mouse) small intestine exhibits many of the same changes that occur in CF patients, including excessive mucus accumulation, impaired intestinal transit, bacterial overgrowth, and an inflammatory response [15], [16]. Inflammation in the CF mouse intestine has characteristics of an innate response that includes an influx of mast cells, mainly into the muscularis externa tissue [17].
###end p 13
###begin p 14
###xml 97 101 97 101 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0004283-Barbara1">[18]</xref>
###xml 196 200 196 200 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0004283-Wood1">[19]</xref>
###xml 308 312 308 312 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0004283-Goldhill1">[20]</xref>
###xml 475 479 475 479 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0004283-Wang1">[21]</xref>
###xml 513 516 513 516 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0004283-Serna1">[2]</xref>
###xml 518 522 518 522 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0004283-Barbara1">[18]</xref>
###xml 524 528 524 528 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0004283-Fargeas1">[22]</xref>
###xml 529 533 529 533 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0004283-VanNassauw1">[24]</xref>
###xml 554 562 554 562 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">in vitro</italic>
###xml 668 672 668 672 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0004283-Sand1">[25]</xref>
Mast cells have been implicated in various conditions where gastrointestinal motility is altered [18]. Mast cells can stimulate motility during acute intestinal infection with pathogenic bacteria [19]. Mast cells produce histamine and serotonin, both of which can stimulate enteric smooth muscle contraction [20]. In other conditions mast cells are associated with impaired motility, often due to deleterious effects of mast cell proteases on the interstitial cells of Cajal [21] or on the enteric nervous system [2], [18], [22]-[24]. For example, using in vitro co-cultures of enteric nerves with peritoneal mast cells, it was shown that mast cells damage the nerves [25]. Inclusion of the mast cell stabilizer doxantrazole in the culture system prevented nerve cell damage demonstrating the importance of mast cell activity.
###end p 14
###begin p 15
###xml 348 355 348 355 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">in vivo</italic>
###xml 15 20 <span type="species:ncbi:10090">mouse</span>
Because the CF mouse small intestine has impaired transit and a dramatic increase in mast cells in the muscularis, we hypothesized that the mast cells may play a role in slowed gastrointestinal transit in these animals. To test this, we used various agents to stabilize or stimulate mast cells, and measured the effects on gastrointestinal transit in vivo.
###end p 15
###begin title 16
Methods
###end title 16
###begin title 17
Ethics Statement
###end title 17
###begin p 18
All animal procedures were approved by the Institutional Animal Care and Use Committee.
###end p 18
###begin title 19
Materials
###end title 19
###begin p 20
Unless otherwise specified, all chemicals were obtained from Sigma-Aldrich (St. Louis, MO, USA).
###end p 20
###begin title 21
Animals
###end title 21
###begin p 22
###xml 0 4 0 4 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Cftr</italic>
###xml 20 26 20 26 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">tm1UNC</sup>
###xml 15 26 15 26 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">(Cftr<sup>tm1UNC</sup></italic>
###xml 190 194 190 194 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0004283-DeLisle3">[26]</xref>
###xml 196 200 196 200 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Cftr</italic>
###xml 247 251 247 251 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Cftr</italic>
###xml 266 270 266 270 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Cftr</italic>
###xml 283 287 283 287 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Cftr</italic>
###xml 571 581 571 581 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">ad libitum</italic>
###xml 654 658 654 658 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0004283-Eckman1">[27]</xref>
###xml 824 828 824 828 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0004283-Kalia1">[28]</xref>
###xml 854 858 854 858 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0004283-Steiner1">[29]</xref>
###xml 860 864 860 864 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0004283-Szabo1">[30]</xref>
###xml 894 898 894 898 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0004283-Brown1">[31]</xref>
###xml 1009 1013 1009 1013 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0004283-Scott1">[32]</xref>
###xml 10 14 <span type="species:ncbi:10090">mice</span>
###xml 133 137 <span type="species:ncbi:10090">mice</span>
###xml 206 210 <span type="species:ncbi:10090">mice</span>
###xml 277 281 <span type="species:ncbi:10090">mice</span>
###xml 293 297 <span type="species:ncbi:10090">mice</span>
###xml 381 385 <span type="species:ncbi:10090">Mice</span>
###xml 557 561 <span type="species:ncbi:10090">mice</span>
Cftr(+/-) mice (Cftrtm1UNC) were originally obtained from the Jackson Laboratory (Bar Harbor, ME, USA). As previously described, the mice were bred to be congenic on the C57BL/6J background [26]. Cftr(+/-) mice were bred to obtain wild type (WT) [Cftr(+/+)] and CF [Cftr(-/-)] mice. Cftr(+/-) mice, which are phenotypically indistinguishable from WT, were used occasionally as WT. Mice of both sexes were used between 6-7 weeks of age and no gender-related differences in the measured parameters were observed. To prevent lethal intestinal obstruction, all mice were fed ad libitum a complete elemental liquid diet (Peptamen; Nestle, Deerfield, IL, USA) [27]. The following mast cell stabilizers were administered at doses derived from published work, by addition to the liquid diet for three weeks: ketotifen (1 mg/kg-day) [28], cromolyn (10 mg/kg-day) [29], [30]; doxantrazole (10 mg/kg-day) [31]. The mast cell stimulator compound 48/80 was administered acutely by i.p. injection of 0.75 mg/kg body weight [32] 30 min before gavage of the motility tracer (see below).
###end p 22
###begin title 23
Measurement of gastric emptying and gastrointestinal transit
###end title 23
###begin p 24
###xml 67 71 67 71 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0004283-DeLisle2">[15]</xref>
###xml 82 86 <span type="species:ncbi:10090">mice</span>
###xml 167 171 <span type="species:ncbi:10090">mice</span>
###xml 260 264 <span type="species:ncbi:10090">mice</span>
Gastric emptying and transit were measured as previously described [15]. Briefly, mice were fasted overnight with free access to water. In the morning between 8-9 AM, mice were gavaged with 100 microl 25 mg/ml rhodamine dextran (MW = 70000). After 20 min, the mice were killed and the gastrointestinal tract was divided into stomach, 10 equal segments of small intestine, and large intestine. The stomach and intestinal segments were flushed and the concentration of the tracer was determined fluorometrically in a Synergy HT microplate reader (BioTek, Winooski, Vermont, USA). Gastric emptying was calculated as the percent of tracer remaining in the stomach relative to the total amount recovered from the stomach and intestine. For measurement of small intestinal transit the fluorescence data were expressed per segment relative to the total in the intestine. For some experiments the post-gavage time was 90 min.
###end p 24
###begin title 25
Mast cell histochemistry
###end title 25
###begin p 26
###xml 156 160 156 160 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0004283-Gersch1">[33]</xref>
###xml 162 166 162 166 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0004283-Braga1">[34]</xref>
###xml 233 237 233 237 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0004283-Stevens1">[35]</xref>
Tissue was fixed with 4% paraformaldehyde and paraffin sections were prepared. Sections were stained with toluidine blue which stains all mature mast cells [33], [34] by binding to serglycin proteoglycans in their secretory granules [35]. Slides were imaged on a Nikon Diaphot microscope equipped with a SPOT RT-KE digital camera (Diagnostic Instruments, Sterling Heights, MI, USA). Mast cells were counted in images of the stained slides by an observer unaware of the sample identities. Tissue areas were calculated using NIH Image J software.
###end p 26
###begin title 27
Statistical analysis
###end title 27
###begin p 28
###xml 138 139 138 139 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">P</italic>
Statistical significance was determined by ANOVA with a post-hoc Fisher's least significant difference test (Systat, Chicago, IL, USA). A P-value of <0.05 was considered significant.
###end p 28
###begin title 29
Results
###end title 29
###begin p 30
###xml 232 236 232 236 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0004283-Norkina2">[17]</xref>
###xml 452 465 452 465 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="pone-0004283-g001">Fig. 1A and B</xref>
###xml 625 631 625 631 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="pone-0004283-g002">Fig. 2</xref>
###xml 737 741 737 741 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0004283-Gersch1">[33]</xref>
###xml 99 104 <span type="species:ncbi:10090">mouse</span>
###xml 143 148 <span type="species:ncbi:10090">mouse</span>
###xml 227 231 <span type="species:ncbi:10090">mice</span>
###xml 294 299 <span type="species:ncbi:10090">mouse</span>
###xml 732 736 <span type="species:ncbi:10090">mice</span>
The aim of this study was to test the role of mast cells in gastrointestinal dysmotility in the CF mouse. We have previously shown that the CF mouse has many more mast cells in the small intestine as compared to wild type (WT) mice [17]. It was not known if the numbers of mast cells in the CF mouse stomach also differed, so we first examined this in wild type (WT) and CF stomachs. Mast cells were readily observed in both WT and CF stomach tissues (Fig. 1A and B, respectively). There was no significant difference in the numbers of mucosal or connective tissue/muscularis externa mast cells comparing WT and CF stomachs (Fig. 2). The density of mast cells we measured in the stomach agrees well with previous reports on healthy mice [33].
###end p 30
###begin title 31
###xml 43 48 <span type="species:ncbi:10090">mouse</span>
Histochemistry for mast cells in WT and CF mouse stomach and small intestine.
###end title 31
###begin p 32
Sections were stained with toluidine blue and mast cells identified by their metachromatic staining. (A) Wild type stomach; (B) CF Stomach; (C) Wild type small intestine; (D) CF small intestine. Arrowheads indicate mast cells. Representative from 7 WT and 7 CF stomachs.
###end p 32
###begin title 33
###xml 51 55 <span type="species:ncbi:10090">mice</span>
Quantitation of mast cells in stomach of WT and CF mice.
###end title 33
###begin p 34
There were no significant differences in the numbers of mast cells per unit area in the CF stomach as compared to WT, in either mucosa or connective tissue (CT, which included the muscularis externa). Data are means +/- SEM. (n = 7 WT, 7 CF stomachs)
###end p 34
###begin p 35
###xml 167 171 167 171 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0004283-Norkina2">[17]</xref>
###xml 173 180 173 180 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="pone-0004283-g001">Fig. 1C</xref>
###xml 267 271 267 271 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0004283-Gersch1">[33]</xref>
###xml 273 277 273 277 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0004283-Knight1">[36]</xref>
###xml 279 283 279 283 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0004283-Grimbaldeston1">[37]</xref>
###xml 387 394 387 394 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="pone-0004283-g001">Fig. 1D</xref>
###xml 63 68 <span type="species:ncbi:10090">mouse</span>
Our previous work showed that in the small intestine of the CF mouse in comparison to WT, there are 50-100 fold more mast cells, principally in the muscularis externa [17] (Fig. 1C). In contrast, mast cells are rare in the WT intestine, consistent with other reports [33], [36], [37]. The occasional mast cells that were observed in the WT intestine were mostly in the peritoneal space (Fig. 1D) and none were in the muscualris externa.
###end p 35
###begin p 36
###xml 466 472 466 472 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="pone-0004283-g003">Fig. 3</xref>
###xml 474 475 474 475 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="pone-0004283-g004">4</xref>
###xml 613 619 613 619 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="pone-0004283-g003">Fig. 3</xref>
###xml 801 808 801 808 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="pone-0004283-g003">Fig. 3A</xref>
###xml 970 977 970 977 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="pone-0004283-g003">Fig. 3B</xref>
###xml 1112 1119 1112 1119 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="pone-0004283-g003">Fig. 3B</xref>
###xml 52 56 <span type="species:ncbi:10090">mice</span>
###xml 342 346 <span type="species:ncbi:10090">mice</span>
###xml 388 392 <span type="species:ncbi:10090">mice</span>
###xml 496 500 <span type="species:ncbi:10090">mice</span>
###xml 677 681 <span type="species:ncbi:10090">mice</span>
###xml 856 860 <span type="species:ncbi:10090">mice</span>
###xml 1008 1012 <span type="species:ncbi:10090">mice</span>
###xml 1403 1407 <span type="species:ncbi:10090">mice</span>
To measure gastric emptying and intestinal transit, mice were fasted overnight and in the morning they were gavaged with rhodamine dextran, a non-absorbable tracer. Twenty or 90 min later, the distribution of the fluorescent tracer was measured in the stomach, small intestine, and large intestine. At 20 min post-gavage in untreated control mice gastric emptying was somewhat less in CF mice as compared to WT, but the difference was not statistically significant (Fig. 3, 4). In both WT and CF mice, at 20 min post-gavage the remainder of the tracer was in the small intestine with none in the large intestine (Fig. 3). When the post-gavage period was extended to 90 min, WT mice showed significant decreases of the tracer in the stomach and small intestine, and an increase in the large intestine (Fig. 3A), as compared to the 20 min WT data. In the CF mice at 90 min post-gavage, there was significantly less tracer in the stomach as compared to the 20 min CF data (Fig. 3B). In comparison to WT, the CF mice had significantly more tracer in the stomach and small intestine, and less in the large intestine (Fig. 3B) at 90 min post-gavage. We chose to use 20 min post-gavage for the remainder of the experiments. At this time point, the distribution of tracer in the gastrointestinal tract would allow detection of changes in gastric emptying or improved small intestinal transit comparing WT to CF mice after treatment with the mast cell active agents.
###end p 36
###begin title 37
###xml 80 84 <span type="species:ncbi:10090">mice</span>
Distribution of rhodamine dextran along the gastrointestinal tract of WT and CF mice at 20 min and 90 min post-gavage.
###end title 37
###begin p 38
###xml 74 81 74 81 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="sec" rid="s2">Methods</xref>
###xml 488 489 486 487 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">P</italic>
###xml 572 573 570 571 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">P</italic>
###xml 17 21 <span type="species:ncbi:10090">mice</span>
###xml 127 131 <span type="species:ncbi:10090">mice</span>
###xml 313 317 <span type="species:ncbi:10090">mice</span>
###xml 326 330 <span type="species:ncbi:10090">mice</span>
###xml 357 361 <span type="species:ncbi:10090">mice</span>
###xml 390 394 <span type="species:ncbi:10090">mice</span>
###xml 403 407 <span type="species:ncbi:10090">mice</span>
###xml 434 438 <span type="species:ncbi:10090">mice</span>
###xml 562 566 <span type="species:ncbi:10090">mice</span>
Overnight fasted mice were gavaged with a bolus of rhodamine dextran (see Methods). At either 20 min or 90 min post-gavage the mice were sacrificed and the distribution of the fluorescence in the stomach (St), small intestine (SI) and large intestine (LI) was measured and expressed relative to the total. (A) WT mice (n = 28 mice 20 min post-gavage, n = 8 mice 90 min post-gavage); (B) CF mice (n = 14 mice 20 min post-gavage, n = 7 mice 90 min post-gavage). Data are means +/- SEM. (*) P<0.05 comparing 20 min vs 90 min data for the same organ and genotype of mice. (+) P<0.05 comparing CF vs WT for the same organ and post-gavage time.
###end p 38
###begin title 39
###xml 30 34 <span type="species:ncbi:10090">mice</span>
Gastric emptying in WT and CF mice and effect of mast cell agents.
###end title 39
###begin p 40
###xml 74 81 74 81 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="sec" rid="s2">Methods</xref>
###xml 652 653 650 651 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">P</italic>
###xml 762 765 760 763 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0004283-DeLisle1">[1]</xref>
###xml 17 21 <span type="species:ncbi:10090">mice</span>
###xml 110 114 <span type="species:ncbi:10090">mice</span>
###xml 723 727 <span type="species:ncbi:10090">mice</span>
Overnight fasted mice were gavaged with a bolus of rhodamine dextran (see Methods). At 20 min post-gavage the mice were sacrificed and the distribution of the fluorescence in the stomach and small intestine was measured. Gastric emptying is expressed as fraction of total fluorescence which has exited the stomach in the 20 min post-gavage period. Con = control (n = 28 WT, n = 14 CF); Ket = ketotifen, 3 week treatment (n = 10 WT, n = 6 CF); Crom = cromolyn 3 week treatment (n = 11 WT, n = 7 CF); Dox = doxantrazole 3 week treatment (n = 5 WT , n = 8 CF); 48/80 = compound 48/80 acute i.p. injection (n = 4 WT, n = 6 CF). Data are means +/- SEM. (*) P<0.05 vs Control of the same genotype. Data for the control WT and CF mice include values from previous work [1].
###end p 40
###begin p 41
###xml 373 383 373 383 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="sec" rid="s4">Discussion</xref>
###xml 96 100 <span type="species:ncbi:10090">mice</span>
To assess the effects of mast cells on gastric emptying and small intestinal transit we treated mice with various mast cell stabilizers. There are several drugs known to stabilize mast cells, and there is some specificity as to whether mucosal or connective tissue mast cells are affected. Because of the uncertainty of the phenotype of mast cells in the CF intestine (see Discussion) and which drugs would act on which type of mast cells, we used three different drugs.
###end p 41
###begin p 42
###xml 224 230 224 230 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="pone-0004283-g004">Fig. 4</xref>
###xml 372 385 372 385 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="pone-0004283-g005">Fig. 5C and D</xref>
###xml 218 222 <span type="species:ncbi:10090">mice</span>
###xml 366 370 <span type="species:ncbi:10090">mice</span>
The first drug used was ketotifen, which stabilizes connective tissue mast cells and is also a histamine H1 receptor antagonist. Ketotifen treatment for three weeks had no effect on gastric emptying in either WT or CF mice (Fig. 4). Ketotifen also did not affect the distribution of the tracer along the small intestine (small intestinal transit) in either WT or CF mice (Fig. 5C and D).
###end p 42
###begin title 43
Transit of rhodamine dextran in the small intestine and effect of mast cell agents.
###end title 43
###begin p 44
###xml 74 81 74 81 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="sec" rid="s2">Methods</xref>
###xml 772 773 770 771 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">P</italic>
###xml 838 839 836 837 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">P</italic>
###xml 959 962 957 960 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0004283-DeLisle1">[1]</xref>
###xml 17 21 <span type="species:ncbi:10090">mice</span>
###xml 110 114 <span type="species:ncbi:10090">mice</span>
###xml 920 924 <span type="species:ncbi:10090">mice</span>
Overnight fasted mice were gavaged with a bolus of rhodamine dextran (see Methods). At 20 min post-gavage the mice were sacrificed and the distribution of the fluorescence in 10 segments (proximal to distal) of the small intestine was measured and expressed relative to the total fluorescence. (A) WT Control (n = 28); (B) CF Control (n = 14); (C) Ketotifen, 3 week treatment of WT (n = 10); (D) Ketotifen, 3 week treatment of CF (n = 6); (E) Cromolyn, 3 week treatment of WT (n = 11); (F) Cromolyn, 3 week treatment of CF (n = 7); (G) Doxantrazole, 3 week treatment of WT (n = 5); (H) Doxantrazole, 3 week treatment of CF (n = 8); (I) Compound 48/80, acute i.p. injection of WT (n = 4); (J) Compound 48/80, acute i.p. injection of CF (n = 6). Data are means +/- SEM. (*) P<0.05 vs control, same genotype and same intestinal segment; (+) P<0.05 CF vs WT, same segment and treatment group. Data for the control WT and CF mice include values from previous work [1].
###end p 44
###begin p 45
###xml 138 144 138 144 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="pone-0004283-g004">Fig. 4</xref>
###xml 287 294 287 294 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="pone-0004283-g005">Fig. 5E</xref>
###xml 383 390 383 390 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="pone-0004283-g005">Fig. 5F</xref>
###xml 132 136 <span type="species:ncbi:10090">mice</span>
###xml 153 157 <span type="species:ncbi:10090">mice</span>
###xml 360 365 <span type="species:ncbi:10090">mouse</span>
The second drug used was cromolyn, which stabilizes mucosal mast cells. Cromolyn was without effect on gastric emptying in WT or CF mice (Fig. 4). In WT mice treated with cromolyn, the tracer was more evenly distributed along the length of the small intestine as compared to control WT (Fig. 5E). Cromolyn had no effect on the distribution of tracer in the CF mouse small intestine (Fig. 5F).
###end p 45
###begin p 46
###xml 215 221 215 221 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="pone-0004283-g004">Fig. 4</xref>
###xml 345 352 345 352 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="pone-0004283-g005">Fig. 5G</xref>
###xml 401 408 401 408 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="pone-0004283-g005">Fig. 5H</xref>
###xml 164 168 <span type="species:ncbi:10090">mice</span>
###xml 209 213 <span type="species:ncbi:10090">mice</span>
###xml 339 343 <span type="species:ncbi:10090">mice</span>
###xml 395 399 <span type="species:ncbi:10090">mice</span>
Doxantrazole, a drug that targets both connective tissue and mucosal mast cells, was the third one used. There was a significant increase in gastric emptying in WT mice treated with doxantrazole but not in CF mice (Fig. 4). Doxantrazole caused a slight but significant change in the distribution of the tracer in the small intestine of WT mice (Fig. 5G) but the effect was not significant in CF mice (Fig. 5H).
###end p 46
###begin p 47
###xml 245 251 245 251 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="pone-0004283-g004">Fig. 4</xref>
###xml 423 424 423 424 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">P</italic>
###xml 434 440 434 440 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="pone-0004283-g004">Fig. 4</xref>
###xml 638 645 638 645 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="pone-0004283-g005">Fig. 5I</xref>
###xml 777 784 777 784 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="pone-0004283-g005">Fig. 5J</xref>
###xml 239 243 <span type="species:ncbi:10090">mice</span>
###xml 260 264 <span type="species:ncbi:10090">mice</span>
###xml 345 349 <span type="species:ncbi:10090">mice</span>
###xml 449 453 <span type="species:ncbi:10090">mice</span>
###xml 582 586 <span type="species:ncbi:10090">mice</span>
###xml 754 759 <span type="species:ncbi:10090">mouse</span>
###xml 880 884 <span type="species:ncbi:10090">mice</span>
###xml 919 923 <span type="species:ncbi:10090">mice</span>
We next tested the effect of stimulation of mast cells by compound 48/80, administered as an i.p. injection 30 min before gavage of the motility tracer. As compared to control, compound 48/80 significantly increased gastric emptying in WT mice (Fig. 4). In CF mice compound 48/80 had a small effect on gastric emptying as compared to control CF mice, but the difference did not reach the level of statistical significance (P = 0.08) (Fig. 4). In WT mice treated with compound 48/80, the distribution of the fluorescent tracer in the small intestine was more even than in control WT mice, but the effect was not statistically significant (Fig. 5I). In contrast, mast cell activation caused a significant change in the distribution of the tracer in the CF mouse small intestine (Fig. 5J). Whereas there was little tracer past the second segment of the small intestine in control CF mice, in the compound 48/80 treated CF mice there was significantly less tracer in the first segment and more in the third segment.
###end p 47
###begin title 48
Discussion
###end title 48
###begin p 49
###xml 209 213 209 213 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0004283-Gersch1">[33]</xref>
###xml 215 219 215 219 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0004283-Grimbaldeston1">[37]</xref>
###xml 608 611 608 611 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0004283-DeLisle1">[1]</xref>
###xml 613 617 613 617 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0004283-Norkina1">[16]</xref>
###xml 752 756 752 756 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0004283-Norkina1">[16]</xref>
###xml 105 110 <span type="species:ncbi:10090">mouse</span>
###xml 156 160 <span type="species:ncbi:10090">mice</span>
###xml 236 242 <span type="species:ncbi:9606">humans</span>
###xml 337 342 <span type="species:ncbi:10090">mouse</span>
###xml 651 655 <span type="species:ncbi:10090">mice</span>
###xml 747 751 <span type="species:ncbi:10090">mice</span>
In this study we investigated the potential role of mast cells in gastrointestinal dysmotility in the CF mouse model of cystic fibrosis. Whereas healthy WT mice have very few mast cells in the small intestine [33], [37], in contrast to humans where intestinal mast cells are common, there is a dramatic elevation of mast cells in the CF mouse small intestine. This influx of mast cells in the CF small intestine is likely in response to the bacterial overgrowth that occurs. The bacteria that overgrow the CF small intestine are opportunistic and they colonize the mucus that accumulates in the CF intestine [1], [16]. When bacterial overgrowth in CF mice is treated with oral antibiotics, the level of mast cells is reduced to that of control WT mice [16].
###end p 49
###begin p 50
###xml 229 234 <span type="species:ncbi:10090">mouse</span>
###xml 411 416 <span type="species:ncbi:10090">mouse</span>
###xml 546 550 <span type="species:ncbi:10090">mice</span>
###xml 565 569 <span type="species:ncbi:10090">mice</span>
Because mast cells have been shown to affect gastrointestinal motility in various conditions, including in the bacterially infected intestine, we hypothesized that mast cells would play an important role in dysmotility in the CF mouse gastrointestinal tract. However, using a variety of mast cell stabilizing drugs, there was no significant improvement in gastric emptying or small intestinal transit in the CF mouse. There was a small but significant increase in small intestinal transit after activation of mast cells with compound 48/80 in CF mice but not in WT mice. This demonstrates that the increased numbers of mast cells in the CF intestine can affect intestinal motility, but their presence alone does not underlie the dysmotility of the CF gut.
###end p 50
###begin p 51
###xml 135 139 135 139 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0004283-Scudamore1">[38]</xref>
###xml 141 145 141 145 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0004283-Welle1">[39]</xref>
###xml 402 406 402 406 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0004283-Norkina2">[17]</xref>
###xml 609 614 609 614 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Mcpt1</italic>
###xml 639 644 639 644 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Mcpt2</italic>
###xml 668 672 668 672 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Cma2</italic>
###xml 686 691 686 691 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Mcp10</italic>
###xml 725 729 725 729 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Cpa3</italic>
###xml 761 766 761 766 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Mcptl</italic>
###xml 768 772 768 772 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0004283-Norkina2">[17]</xref>
###xml 894 899 894 899 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Mcpt4</italic>
###xml 913 917 913 917 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Cma1</italic>
###xml 931 936 931 936 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Mcpt5</italic>
###xml 954 959 951 956 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Tpsb2</italic>
###xml 973 978 970 975 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Mcpt6</italic>
###xml 1007 1013 997 1003 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Tpsab1</italic>
###xml 1027 1032 1017 1022 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Mcpt7</italic>
###xml 380 385 <span type="species:ncbi:10090">mouse</span>
###xml 489 494 <span type="species:ncbi:10090">mouse</span>
###xml 522 527 <span type="species:ncbi:10090">mouse</span>
Mast cells display tremendous diversity depending on their tissue site and the nature of the inflammation to which they are responding [38], [39]. Two main ways to classify mast cells are based on their tissue localization and on their enzymatic profile. By an earlier Affymetrix GeneChip analysis, all of the 11 mast cell protease genes on the array were called absent in the WT mouse small intestine [17]. This is consistent with the very low numbers of mature mast cells in the healthy mouse small intestine. In the CF mouse intestine several mast cell protease genes were expressed: mast cell protease 1 (Mcpt1), mast cell protease 2 (Mcpt2), mast cell chymase 2 (Cma2, also called Mcp10), mast cell carboxypeptidase A3 (Cpa3), and mast cell protease-like (Mcptl) [17]. There was unmeasurable expression of the other mast cell markers on the arrays of the CF samples [mast cell protease 4 (Mcpt4), chymase 1 (Cma1, also called Mcpt5), trypase beta2 (Tpsb2, also called Mcpt6), and tryptase alpha/beta1 (Tpsab1, also called Mcpt7)].
###end p 51
###begin p 52
###xml 217 224 217 224 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="pone-0004283-g001">Fig. 1D</xref>
###xml 266 270 266 270 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0004283-Norkina2">[17]</xref>
###xml 720 724 720 724 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0004283-Scudamore1">[38]</xref>
###xml 725 729 725 729 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0004283-Metcalfe1">[41]</xref>
###xml 116 121 <span type="species:ncbi:10090">mouse</span>
###xml 535 539 <span type="species:ncbi:10090">mice</span>
Based on tissue localization and protease gene expression, it is not clear how to classify the mast cells in the CF mouse small intestine. These mast cells are predominantly localized to the muscularis externa layer (Fig. 1D), with occasional cells in the submucosa [17]. This localization would classify them as connective tissue mast cells. However, their protease expression profile does not fit the distinct patterns of mucosal vs. connective tissue mast cells (e.g., Mcpt1 and Mcpt2 are regarded as a mucosal mast cell markers in mice, and Cpa3 is connective tissue mast cell marker, but all are expressed in the CF intestine; and whereas Cma1 is a connective tissue marker it is not expressed in the CF intestine) [38]-[41].
###end p 52
###begin p 53
###xml 293 298 <span type="species:ncbi:10090">mouse</span>
Because of the uncertainty of how to classify the mast cells in the CF small intestine, we used a variety of mast cell stabilizers. However, none of the mast cell stabilizers which have activity on the different types of mast cells had a positive effect on gastrointestinal motility in the CF mouse.
###end p 53
###begin p 54
###xml 113 117 <span type="species:ncbi:10090">mice</span>
###xml 180 184 <span type="species:ncbi:10090">mice</span>
###xml 302 306 <span type="species:ncbi:10090">mice</span>
In summary, this study shows that mast cell stabilizers were not able to improve gastrointestinal motility in CF mice. There was a small increase in small intestinal transit in CF mice when mast cells were stimulated but this effect was small and transit was still much less than in healthy WT control mice. Thus, unlike other conditions where dysmotility occurs, mast cells are not likely to be a useful therapeutic target to improve gastrointestinal motility in CF.
###end p 54
###begin title 55
References
###end title 55
###begin article-title 56
###xml 129 134 <span type="species:ncbi:10090">mouse</span>
Effects of laxative and N-acetylcysteine on mucus accumulation, bacterial load, transit, and inflammation in the cystic fibrosis mouse small intestine.
###end article-title 56
###begin article-title 57
###xml 205 225 <span type="species:ncbi:6334">Trichinella spiralis</span>
###xml 246 249 <span type="species:ncbi:10116">Rat</span>
Mast Cell Stabilizer Ketotifen [4-(1-Methyl-4-piperidylidene)-4H-benzo[4,5]cyclohepta[1,2-b]thiophen-10(9 H)-one Fumarate] Prevents Mucosal Mast Cell Hyperplasia and Intestinal Dysmotility in Experimental Trichinella spiralis Inflammation in the Rat.
###end article-title 57
###begin article-title 58
Selective jejunal manipulation causes postoperative pan-enteric inflammation and dysmotility.
###end article-title 58
###begin article-title 59
###xml 94 102 <span type="species:ncbi:9606">patients</span>
Evidence of chronic inflammation in morphologically normal small intestine of cystic fibrosis patients.
###end article-title 59
###begin article-title 60
Intestinal inflammation in cystic fibrosis.
###end article-title 60
###begin article-title 61
Intestinal inflammation is a frequent feature of cystic fibrosis and is reduced by probiotic administration.
###end article-title 61
###begin article-title 62
Risk factors for small bowel bacterial overgrowth in cystic fibrosis.
###end article-title 62
###begin article-title 63
Bowel dysfunction in cystic fibrosis: importance of breath testing.
###end article-title 63
###begin article-title 64
Prolonged small-intestinal transit time in cystic fibrosis.
###end article-title 64
###begin article-title 65
###xml 64 72 <span type="species:ncbi:9606">patients</span>
Oro-caecal transit time and intra-luminal pH in cystic fibrosis patients with distal intestinal obstruction syndrome.
###end article-title 65
###begin article-title 66
Small intestinal permeability and orocaecal transit time in cystic fibrosis.
###end article-title 66
###begin article-title 67
Intestinal permeability to 51Cr-EDTA and orocecal transit time in cystic fibrosis.
###end article-title 67
###begin article-title 68
###xml 46 54 <span type="species:ncbi:9606">children</span>
Gut hormones and gastrointestinal motility in children with cystic fibrosis.
###end article-title 68
###begin article-title 69
Gastrointestinal pH, motility/transit and permeability in cystic fibrosis.
###end article-title 69
###begin article-title 70
###xml 64 69 <span type="species:ncbi:10090">Mouse</span>
Altered Transit and Bacterial Overgrowth in the Cystic Fibrosis Mouse Small Intestine.
###end article-title 70
###begin article-title 71
###xml 85 90 <span type="species:ncbi:10090">mouse</span>
Bacterial overgrowth in the cystic fibrosis transmembrane conductance regulator null mouse small intestine.
###end article-title 71
###begin article-title 72
###xml 36 41 <span type="species:ncbi:10090">mouse</span>
Inflammation of the cystic fibrosis mouse small intestine.
###end article-title 72
###begin article-title 73
Functional gastrointestinal disorders and mast cells: implications for therapy.
###end article-title 73
###begin article-title 74
Effects of bacteria on the enteric nervous system: implications for the irritable bowel syndrome.
###end article-title 74
###begin article-title 75
###xml 18 23 <span type="species:ncbi:10090">mouse</span>
Neural control of mouse small intestinal longitudinal muscle: interactions with inflammatory mediators.
###end article-title 75
###begin article-title 76
Ultrastructural injury to interstitial cells of Cajal and communication with mast cells in Crohn's disease.
###end article-title 76
###begin article-title 77
###xml 110 114 <span type="species:ncbi:10116">rats</span>
Relationship between mast cell degranulation and jejunal myoelectric alterations in intestinal anaphylaxis in rats.
###end article-title 77
###begin article-title 78
Review article: gastrointestinal sensory and motor disturbances in inflammatory bowel disease-clinical relevance and pathophysiological mechanisms.
###end article-title 78
###begin article-title 79
The bidirectional communication between neurons and mast cells within the gastrointestinal tract.
###end article-title 79
###begin article-title 80
Mast cells reduce survival of myenteric neurons in culture.
###end article-title 80
###begin article-title 81
###xml 90 95 <span type="species:ncbi:10090">mouse</span>
Changes in the exocrine pancreas secondary to altered small intestinal function in the CF mouse.
###end article-title 81
###begin article-title 82
###xml 65 70 <span type="species:ncbi:10090">mouse</span>
Dietary changes improve survival of CFTR S489X homozygous mutant mouse.
###end article-title 82
###begin article-title 83
###xml 49 52 <span type="species:ncbi:10116">rat</span>
Mast cell stabilization prevents ethanol-induced rat gastric mucosal injury: mechanisms of protection.
###end article-title 83
###begin article-title 84
Mast cells mediate the microvascular inflammatory response to systemic hypoxia.
###end article-title 84
###begin article-title 85
The role of mast cells in mucosal permeability changes during ischemia-reperfusion injury of the small intestine.
###end article-title 85
###begin article-title 86
###xml 93 96 <span type="species:ncbi:10116">rat</span>
Role of mast cells, neutrophils and nitric oxide in endotoxin-induced damage to the neonatal rat colon.
###end article-title 86
###begin article-title 87
###xml 79 83 <span type="species:ncbi:10116">rats</span>
Mediation of anaphylaxis-induced jejunal circular smooth muscle contraction in rats.
###end article-title 87
###begin article-title 88
###xml 46 50 <span type="species:ncbi:10090">mice</span>
Mast cells and macrophages in normal C57/BL/6 mice.
###end article-title 88
###begin article-title 89
Serglycin proteoglycan is required for secretory granule integrity in mucosal mast cells.
###end article-title 89
###begin article-title 90
###xml 35 40 <span type="species:ncbi:10090">mouse</span>
###xml 45 50 <span type="species:ncbi:9606">human</span>
Protease-proteoglycan complexes of mouse and human mast cells and importance of their beta-tryptase-heparin complexes in inflammation and innate immunity.
###end article-title 90
###begin article-title 91
###xml 94 98 <span type="species:ncbi:10090">mice</span>
Aberrant mucosal mast cell protease expression in the enteric epithelium of nematode-infected mice lacking the integrin alphavbeta6, a transforming growth factor-beta1 activator.
###end article-title 91
###begin article-title 92
###xml 53 57 <span type="species:ncbi:10090">Mice</span>
Mast Cell-Deficient W-sash c-kit Mutant KitW-sh/W-sh Mice as a Model for Investigating Mast Cell Biology in Vivo.
###end article-title 92
###begin article-title 93
###xml 78 83 <span type="species:ncbi:10090">mouse</span>
###xml 191 195 <span type="species:ncbi:10090">mice</span>
Mast cell heterogeneity in the gastrointestinal tract: variable expression of mouse mast cell protease-1 (mMCP-1) in intraepithelial mucosal mast cells in nematode-infected and normal BALB/c mice.
###end article-title 93
###begin article-title 94
Development, significance, and heterogeneity of mast cells with particular regard to the mast cell-specific proteases chymase and tryptase.
###end article-title 94
###begin article-title 95
###xml 83 103 83 103 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Trichinella spiralis</italic>
###xml 64 68 <span type="species:ncbi:10090">mice</span>
###xml 83 103 <span type="species:ncbi:6334">Trichinella spiralis</span>
Mast cells that reside at different locations in the jejunum of mice infected with Trichinella spiralis exhibit sequential changes in their granule ultrastructure and chymase phenotype.
###end article-title 95
###begin article-title 96
Mast cells.
###end article-title 96
###begin p 97
###xml 0 21 0 21 <bold xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Competing Interests: </bold>
Competing Interests: The authors have declared that no competing interests exist.
###end p 97
###begin p 98
###xml 0 9 0 9 <bold xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Funding: </bold>
Funding: This work was supported by a grant from the Cystic Fibrosis Foundation to RCD. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.
###end p 98

